Molecular Breast Imaging of HER2-Positive Breast Cancer in the Era of PHERGain Trial: The past, the Present, and the Prospects

Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print.

Source: Cancer Biotherapy and Radiopharmaceuticals - May 3, 2024 Category: Cancer & Oncology Authors: Luca Filippi Martin W. Brechbiel Source Type: research